Found: 58
Select item for more details and to access through your institution.
Oral ondansetron is highly active as rescue antiemetic treatment for moderately emetogenic chemotherapy: results of a randomized phase II study.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Time to First Tumor Progression as Outcome Predictor of a Second Trasuzumab-Based Therapy beyond Progression in HER-2 Positive Metastatic Breast Cancer.
- Published in:
- Breast Journal, 2010, v. 16, n. 1, p. 66, doi. 10.1111/j.1524-4741.2009.00849.x
- By:
- Publication type:
- Article
Successful Response to Osimertinib Rechallenge after Intervening Chemotherapy in an EGFR T790M-Positive Lung Cancer Patient.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 10, p. 983, doi. 10.1007/s40261-018-0691-8
- By:
- Publication type:
- Article
Osimertinib (AZD9291) and CNS Response in Two Radiotherapy-Naïve Patients with EGFR-Mutant and T790M-Positive Advanced Non-Small Cell Lung Cancer.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 8, p. 683, doi. 10.1007/s40261-016-0411-1
- By:
- Publication type:
- Article
A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 2, p. 207, doi. 10.1007/s40487-024-00267-6
- By:
- Publication type:
- Article
Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 1, p. 163, doi. 10.1007/s40487-023-00251-6
- By:
- Publication type:
- Article
Inflamed Tumor Phenotype as Predictor of Long-Term Response to Pembrolizumab in an EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patient with Acquired Resistance to Afatinib: a Case Report and Review of the Literature.
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 1, p. 291, doi. 10.1007/s40487-022-00183-7
- By:
- Publication type:
- Article
Is There a Role for Multiple Lines of Anti-HER2 Therapies Administered Beyond Progression in HER2-Mutated Non-Small Cell Lung Cancer? A Case Report and Literature Review.
- Published in:
- Oncology & Therapy, 2020, v. 8, n. 2, p. 341, doi. 10.1007/s40487-020-00121-5
- By:
- Publication type:
- Article
RET Rearrangement as a Predictor of Unresponsiveness to Immunotherapy in Non-Small Cell Lung Cancer: Report of Two Cases with Review of the Literature.
- Published in:
- Oncology & Therapy, 2020, v. 8, n. 2, p. 333, doi. 10.1007/s40487-020-00116-2
- By:
- Publication type:
- Article
Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01299
- By:
- Publication type:
- Article
Correction to: Phase II study of weekly carboplatin in pretreated adult malignant gliomas.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Phase II study of weekly carboplatin in pretreated adult malignant gliomas.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 144, n. 1, p. 211, doi. 10.1007/s11060-019-03223-x
- By:
- Publication type:
- Article
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 129, n. 2, p. 355, doi. 10.1007/s11060-016-2184-z
- By:
- Publication type:
- Article
New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma.
- Published in:
- Acta Neuropathologica Communications, 2020, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40478-020-01022-4
- By:
- Publication type:
- Article
Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy.
- Published in:
- Genes, 2021, v. 12, n. 7, p. 992, doi. 10.3390/genes12070992
- By:
- Publication type:
- Article
Sensitivity to Immune Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations.
- Published in:
- Genes, 2021, v. 12, n. 5, p. 679, doi. 10.3390/genes12050679
- By:
- Publication type:
- Article
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients.
- Published in:
- Genes, 2021, v. 12, n. 2, p. 273, doi. 10.3390/genes12020273
- By:
- Publication type:
- Article
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma.
- Published in:
- Interactive Cardiovascular & Thoracic Surgery, 2017, v. 25, n. 6, p. 856, doi. 10.1093/icvts/ivx202
- By:
- Publication type:
- Article
miRNAs and resistance to EGFR--TKIs in EGFR-mutant non-small cell lung cancer: beyond 'traditional mechanisms' of resistance.
- Published in:
- Ecancermedicalscience, 2015, v. 9, n. 549-576, p. 1, doi. 10.3332/ecancer.2015.569
- By:
- Publication type:
- Article
Enteric-type adenocarcinoma of the lung harbouring a novel KRAS Q22K mutation with concomitant KRAS polysomy: a case report.
- Published in:
- Ecancermedicalscience, 2015, v. 9, n. 549-576, p. 1, doi. 10.3332/ecancer.2015.559
- By:
- Publication type:
- Article
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer.
- Published in:
- Current Oncology Reports, 2023, v. 25, n. 9, p. 1017, doi. 10.1007/s11912-023-01436-y
- By:
- Publication type:
- Article
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 2, p. 479, doi. 10.1007/s00432-018-2805-3
- By:
- Publication type:
- Article
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01427-8
- By:
- Publication type:
- Article
Clinical Utility of Continuing Trastuzumab Beyond Brain Progression in HER-2-Positive Metastatic Breast Cancer.
- Published in:
- 2007
- By:
- Publication type:
- Letter
The Role of Performance Status in Small-Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment Patterns and Clinical Outcomes Among Patients With ROS1-rearranged Non-small-cell Lung Cancer Progressing on Crizotinib.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and Efficacy of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer Treated Beyond Progression.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 12, p. 1062, doi. 10.3390/diagnostics10121062
- By:
- Publication type:
- Article
Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 9, p. 1058, doi. 10.1080/0284186X.2020.1781249
- By:
- Publication type:
- Article
Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2017, v. 9, n. 6, p. 387, doi. 10.1177/1758834017702820
- By:
- Publication type:
- Article
Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients.
- Published in:
- International Journal of Biological Markers, 2018, v. 33, n. 4, p. 549, doi. 10.1177/1724600818754763
- By:
- Publication type:
- Article
Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00264
- By:
- Publication type:
- Article
Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
- Published in:
- Medical Oncology, 2016, v. 33, n. 2, p. 1, doi. 10.1007/s12032-016-0731-2
- By:
- Publication type:
- Article
Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 482, doi. 10.1186/1471-2407-12-482
- By:
- Publication type:
- Article
Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation.
- Published in:
- BMC Cancer, 2009, v. 9, p. 1, doi. 10.1186/1471-2407-9-101
- By:
- Publication type:
- Article
Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reports.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 10, p. 3041, doi. 10.1007/s00262-021-02938-z
- By:
- Publication type:
- Article
Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.921854
- By:
- Publication type:
- Article
Resistance to TKIs in EGFR-Mutated Non-Small Cell Lung Cancer: From Mechanisms to New Therapeutic Strategies.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143337
- By:
- Publication type:
- Article
CT-Guided Percutaneous Trans-scapular Lung Biopsy in the Diagnosis of Peripheral Pulmonary Lesion Nodules of the Superior Lobes Using Large Needles.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Erratum to: CT-Guided Percutaneous Trans-scapular Lung Biopsy in the Diagnosis of Peripheral Pulmonary Lesion Nodules of the Superior Lobes Using Large Needles.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1405, doi. 10.1007/s00280-011-1632-x
- By:
- Publication type:
- Article
Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 3, p. 687, doi. 10.1007/s00280-010-1369-y
- By:
- Publication type:
- Article
Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme.
- Published in:
- 2010
- By:
- Publication type:
- Report
Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 717, doi. 10.1007/s00280-007-0650-1
- By:
- Publication type:
- Article
Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1047, doi. 10.3390/jcm9041047
- By:
- Publication type:
- Article
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.00839
- By:
- Publication type:
- Article